BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 19170988)

  • 1. The impact of discontinuation of 7-day storage of apheresis platelets (PASSPORT) on recipient safety: an illustration of the need for proper risk assessments.
    Kleinman S; Dumont LJ; Tomasulo P; Bianco C; Katz L; Benjamin RJ; Gajic O; Brecher ME
    Transfusion; 2009 May; 49(5):903-12. PubMed ID: 19170988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of single-donor apheresis platelets for bacterial contamination: the PASSPORT study results.
    Dumont LJ; Kleinman S; Murphy JR; Lippincott R; Schuyler R; Houghton J; Metzel P
    Transfusion; 2010 Mar; 50(3):589-99. PubMed ID: 19929862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006).
    Eder AF; Kennedy JM; Dy BA; Notari EP; Weiss JW; Fang CT; Wagner S; Dodd RY; Benjamin RJ;
    Transfusion; 2007 Jul; 47(7):1134-42. PubMed ID: 17581147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A national survey of transfusion-related acute lung injury risk reduction policies for platelets and plasma in the United States.
    Kleinman S; Grossman B; Kopko P
    Transfusion; 2010 Jun; 50(6):1312-21. PubMed ID: 20456690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viability and function of 8-day-stored apheresis platelets.
    Slichter SJ; Bolgiano D; Jones MK; Christoffel T; Corson J; Rose L; Foley J; Popovsky M; Baril LL; Corda T; Dincecco DM; Snyder EL
    Transfusion; 2006 Oct; 46(10):1763-9. PubMed ID: 17002633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-year experience with aerobic culturing of apheresis and whole blood-derived platelets.
    Kleinman SH; Kamel HT; Harpool DR; Vanderpool SK; Custer B; Wiltbank TB; Nguyen KA; Tomasulo PA
    Transfusion; 2006 Oct; 46(10):1787-94. PubMed ID: 17002636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canadian experience with detection of bacterial contamination in apheresis platelets.
    Ramírez-Arcos S; Jenkins C; Dion J; Bernier F; Delage G; Goldman M
    Transfusion; 2007 Mar; 47(3):421-9. PubMed ID: 17319821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paired in vitro and in vivo comparison of apheresis platelet concentrates stored in platelet additive solution for 1 versus 7 days.
    Shanwell A; Diedrich B; Falker C; Jansson B; Sandgren P; Sundkvist L; Svensson L; Vesterinen M; Gulliksson H
    Transfusion; 2006 Jun; 46(6):973-9. PubMed ID: 16734814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of in vitro storage properties of prestorage pooled whole blood-derived platelets suspended in 100 percent plasma and treated with amotosalen and long-wavelength ultraviolet light.
    Wagner SJ; Skripchenko A; Myrup A; Awatefe H; Thompson-Montgomery D; Moroff G; Carmichael P; Lin L
    Transfusion; 2009 Apr; 49(4):704-10. PubMed ID: 19171001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo evaluation of apheresis platelets stored for 5 days in 65% platelet additive solution/35% plasma.
    Vassallo RR; Adamson JW; Gottschall JL; Snyder EL; Lee W; Houghton J; Elfath MD
    Transfusion; 2010 Nov; 50(11):2376-85. PubMed ID: 20497516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage.
    Skripchenko A; Kurtz J; Moroff G; Wagner SJ
    Transfusion; 2008 Jul; 48(7):1469-77. PubMed ID: 18482181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evaluation of prestorage pooled leukoreduced whole blood-derived platelets stored for up to 7 days.
    Heddle NM; Barty RL; Sigouin CS; Boye DM; Nelson EJ; Blajchman MA; Kelton JG
    Transfusion; 2005 Jun; 45(6):904-10. PubMed ID: 15934988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of simulated shipping conditions (24- or 30-hr interruption of agitation) on the in vitro properties of apheresis platelets during 7-day storage.
    Wagner SJ; Vassallo R; Skripchenko A; Einarson M; Seetharaman S; Moroff G
    Transfusion; 2008 Jun; 48(6):1072-80. PubMed ID: 18373503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Storage time of blood products and transfusion-related acute lung injury.
    Middelburg RA; Borkent-Raven BA; Janssen MP; van de Watering LM; Wiersum-Osselton JC; Schipperus MR; Beckers EA; Briët E; van der Bom JG
    Transfusion; 2012 Mar; 52(3):658-67. PubMed ID: 21950582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets.
    Schrezenmeier H; Walther-Wenke G; Müller TH; Weinauer F; Younis A; Holland-Letz T; Geis G; Asmus J; Bauerfeind U; Burkhart J; Deitenbeck R; Förstemann E; Gebauer W; Höchsmann B; Karakassopoulos A; Liebscher UM; Sänger W; Schmidt M; Schunter F; Sireis W; Seifried E
    Transfusion; 2007 Apr; 47(4):644-52. PubMed ID: 17381623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical comparison of platelet preparation methods.
    Vassallo RR; Murphy S
    Curr Opin Hematol; 2006 Sep; 13(5):323-30. PubMed ID: 16888436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Summary of the AABB Interorganizational Task Force on Bacterial Contamination of Platelets: Fall 2004 impact survey.
    Silva MA; Gregory KR; Carr-Greer MA; Holmberg JA; Kuehnert MJ; Brecher ME;
    Transfusion; 2006 Apr; 46(4):636-41. PubMed ID: 16584441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial contamination of whole-blood-derived platelets: the introduction of sample diversion and prestorage pooling with culture testing in the American Red Cross.
    Benjamin RJ; Kline L; Dy BA; Kennedy J; Pisciotto P; Sapatnekar S; Mercado R; Eder AF
    Transfusion; 2008 Nov; 48(11):2348-55. PubMed ID: 18657074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The practice of reporting transfusion-related acute lung injury: a national survey among clinical and preclinical disciplines.
    Vlaar AP; Wortel K; Binnekade JM; van Oers MH; Beckers E; Gajic O; Schultz MJ; Juffermans NP
    Transfusion; 2010 Feb; 50(2):443-51. PubMed ID: 19804567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routine use of Day 6 and Day 7 platelets with rapid testing: two hospitals assess impact 1 year after implementation.
    Harm SK; Szczepiorkowski ZM; Dunbar NM
    Transfusion; 2018 Apr; 58(4):938-942. PubMed ID: 29332317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.